Drug Combination Details
General Information of the Combination (ID: C36721) | |||||
---|---|---|---|---|---|
Name | Salicylic acid NP Info | + | Methylene blue Drug Info | ||
Structure | + | ||||
Disease |
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
In-vitro Model | MDA-MB-231 | CVCL_0062 | Breast adenocarcinoma | Homo sapiens | ||
Experimental
Result(s) |
Cancer cell killing efficiency of MB increases in the combination with SA due to reduction prevention and stabilization of monomeric form of MB. |
References | ||||
---|---|---|---|---|
Reference 1 | Combination photodynamic therapy of human breast cancer using salicylic acid and methylene blue. Spectrochim Acta A Mol Biomol Spectrosc. 2017 Sep 5;184:198-203. |